glp-1 gip medication long term effects 💉 Semaglutide. Tirzepatide. Retatrutide. What's the difference… and which one is right for you? 🤔 They're not all the same. In this video, Dr. Bafitis breaks down the key differences between these supplements Flavor:Blood Orange MyGLP Challenge

glp-1 gip medication long term effects 💉 Semaglutide. Tirzepatide. Retatrutide. What's the difference… and which one is right for you? 🤔 They're not all the same. In this video, Dr. Bafitis breaks down the key differences between these supplements Flavor:Blood Orange MyGLP Challenge

MyGLP Challenge

The fix is straightforward

supplements

Flavor:Blood Orange

About the Company: • Daiichi Sankyo US is a global #biopharma leader focused on innovative oncology therapies • Merck Group (MSD) is a leading global pharmaceutical company specializing in breakthrough medicines • Both companies are pioneers in antibody-drug conjugate development About the Product: • #Ifinatamab deruxtecan (I-DXd) is a B7-H3–directed #ADC therapy • Designed to deliver #cytotoxic agents directly to cancer cells • Targets extensive-stage small cell lung cancer (#ES-SCLC) Key Highlights: • FDA Priority Review granted for #BiologicsLicense Application • Based on Phase 2 #IDEATE-Lung01 clinical data • Potential first-in-class #B7-H3 targeted therapy • Addresses patients progressing after platinum-based chemotherapy • #PDUFA decision expected in October 2026 Small cell #lungcancer remains one of the most aggressive cancers with limited treatment options after relapse, making targeted therapies like #ADCs highly promising